Six Hospitals Settle with Trump Administration to Close Youth Gender Clinics and Pay Fines

The agreements require hospitals to discontinue puberty blockers, cross-sex hormones, and surgeries for minors while paying undisclosed penalties. Primary endpoints in the deals center on compliance verification through federal audits rather than clinical outcomes. Data from state health departments show these clinics previously served several thousand adolescents annually, with most cases involving co-occurring mental health conditions.

Related enforcement actions build on 2025 executive orders restricting federal funding for pediatric gender medicine and parallel state laws upheld in multiple circuits. Observational cohorts in JAMA Pediatrics and The Lancet Child & Adolescent Health have reported high rates of psychiatric comorbidity and desistance after watchful waiting, yet no large RCT has compared affirmative protocols against therapy-first approaches.

Remaining questions include long-term bone density and fertility effects plus the impact of clinic closures on referral patterns to out-of-state providers. Next studies must track actual service utilization and mental health trajectories using insurance claims data with matched controls rather than self-reported satisfaction.

Federal monitoring will determine whether additional facilities face similar pressure and whether exemptions for research protocols survive legal challenge.